AstraZeneca Strikes Vaccine Deal

AstraZeneca reached a licensing deal with Chinese firm BioKangtai to help provide its adenovirus vector-based COVID-19 vaccine candidate, created by the University of Oxford, to China, AstraZeneca said in a social media post on Thursday. The pair will […]